Kinexus Bioinformatics launches new peptide synthesis facility

New Peptide Array Facility Designed to Expedite the Drug Discovery Process

Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery. A variety of peptide services are being made available by Kinexus to the research community including:

- Protein Labeling, - Screening of peptide arrays like Epitope Mapping, Substitution Analysis, and Peptide Library Screening, - Custom Peptide Synthesis including modified peptides like phosphopeptides, histones, cyclized and labeled peptides, - CelluSpots(TM) Custom Peptide Arrays on Glass Slides, and - CelluSpots(TM) Kinase Substrate Peptide Arrays on Glass Slides.

"Kinexus' peptide-based products strongly complement our existing portfolio of cell signaling, proteomics and bioinformatics services," stated Dr. Steven Pelech, president and Chief Scientific Officer of Kinexus Bioinformatics Corporation. "These new products will give Kinexus customers access to high-throughput peptide synthesis and screening platforms, which will accelerate research in the field of signal transduction. The Peptide Array Facility is the latest addition to a unique integrated suite of proteomics services offered by Kinexus which delivers solutions and services for pharmaceutical, biotechnology, academic, life science, clinical and government research laboratories from around the world.